128 related articles for article (PubMed ID: 12695642)
1. [Influence of prognostic factors on the survival of lung cancer patients].
Plieskiene A; Juozaityte E; Inciūra A; Jarusevicius L; Mazuolis D; Sakalauskas R
Medicina (Kaunas); 2003; 39(3):278-85. PubMed ID: 12695642
[TBL] [Abstract][Full Text] [Related]
2. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy of lung cancer. Optimized radiotherapy improves survival].
Brodin O
Lakartidningen; 1997 May; 94(20):1881-6. PubMed ID: 9190477
[No Abstract] [Full Text] [Related]
5. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
7. [The influence of conformal radiotherapy on survival of lung cancer patients].
Norkus D; Juozaityte E; Inciūra A; Plieskiene A; Mazuolis D
Medicina (Kaunas); 2003; 39(3):271-7. PubMed ID: 12695641
[TBL] [Abstract][Full Text] [Related]
8. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
9. [Radiation therapy of lung carcinoma].
Oertel S; Debus J; Hof H; Bischof M
Radiologe; 2010 Aug; 50(8):669-74. PubMed ID: 20628725
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for lung cancer in the elderly.
Bayman N; Alam N; Faivre-Finn C
Lung Cancer; 2010 May; 68(2):129-36. PubMed ID: 20079949
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
12. [Palliative accelerated irradiation for advanced non-small-cell lung bronchial carcinoma: results of a pilot study].
Nestle U; Nieder C; Walter K; Niewald M; Motaref B; Braun-Fischer A; Ukena D; Sybrecht GW; Schnabel K
Pneumologie; 1999 Aug; 53(8):385-92. PubMed ID: 10483277
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?
Bogart JA
J Clin Oncol; 2004 Mar; 22(5):765-8. PubMed ID: 14990629
[No Abstract] [Full Text] [Related]
14. Survival of patients in clinical stages I-IIIb of non-small-cell lung cancer treated with radiation therapy alone. Results of a population-based study in Southern Saxony-Anhalt.
Bollmann A; Blankenburg T; Haerting J; Kuss O; Schütte W; Dunst J; Neef H;
Strahlenther Onkol; 2004 Aug; 180(8):488-96. PubMed ID: 15292969
[TBL] [Abstract][Full Text] [Related]
15. [The recent progress in chemoradiotherapy of lung cancer].
Ogawara M; Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
[TBL] [Abstract][Full Text] [Related]
16. Radiation treatment of superior sulcus lung carcinoma.
Millar J; Ball D; Worotniuk V; Smith J; Crennan E; Bishop M
Australas Radiol; 1996 Feb; 40(1):55-60. PubMed ID: 8838890
[TBL] [Abstract][Full Text] [Related]
17. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in the treatment of lung cancer.
Macbeth F
Br J Hosp Med; 1996 May 15-Jun 4; 55(10):639-42. PubMed ID: 8762125
[No Abstract] [Full Text] [Related]
19. High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma.
Nakayama H; Satoh H; Kurishima K; Ishikawa H; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):645-50. PubMed ID: 20869582
[TBL] [Abstract][Full Text] [Related]
20. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
